Frequency and Prognosis of JAK2 V617F, Calr, MPL and ASXL1 Mutations in Primary Myelofibrosis

被引：0

作者：

Sorigue, Marc ^{[1
]}

Cabezon, Marta ^{[2
]}

Garcia, Olga ^{[1
]}

Velez, Patricia ^{[3
]}

Marce, Silvia ^{[2
]}

Boque, Concha ^{[3
]}

Xicoy, Blanca ^{[1
]}

Fernandez, Cristalina ^{[4
]}

Xandri, Marisol ^{[2
]}

Casanova, Enric ^{[3
]}

Gallardo, David ^{[4
]}

Milla, Fuensanta ^{[2
]}

Ribera, Josep-Maria ^{[2
]}

Feliu, Evarist ^{[2
]}

Zamora, Lurdes ^{[2
]}

机构：

[1] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, ICO, Josep Carreras Leukemia Res Inst, Badalona, Spain

[2] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, ICO Badalona, Josep Carreras Leukemia Res Inst, Badalona, Spain

[3] Hosp Duran y Reynals, ICO, Lhospitalet De Llobregat, Spain

[4] Hosp Josep Trueta, ICO, Girona, Spain

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[21] CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms [J].

Mikic, Tanja Belcic ;

Pajic, Tadej ;

Sever, Matjaz .

SCIENTIFIC REPORTS, 2019, 9 (1)

[22] Prevalence of the JAK2 V617F and MPL Mutations in Stroke, Abdominal and Peripheral Venous Thrombosis [J].

McCarthy, Niamh ;

McCarron, Sarah L. ;

Langabeer, Stephen E. .

ACTA HAEMATOLOGICA, 2010, 124 (03) :160-161

[23] JAK2 V617F, MPL, and CALR Mutations in Essential Thrombocythaemia and Major Thrombotic Complications: A Single-Institute Retrospective Analysis [J].

Posfai, Eva ;

Marton, Imelda ;

Kiraly, Peter Attila ;

Kotosz, Balazs ;

Kiss-Laszlo, Zsuzsanna ;

Szell, Marta ;

Borbenyi, Zita .

PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (03) :751-758

[24] Comparative thrombotic risk associated with CALR1, CALR2, and JAK2 V617F mutations in essential thrombocythemia [J].

Neupane, Niraj ;

Low, Soon K. ;

Kharel, Himal ;

Bhattarai, Sanket ;

Thapa, Sangharsha ;

Mahmoud, Amir ;

Pokhrel, Nishant B. ;

Din, Mohammad Ammad Ud ;

Kouides, Peter .

AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (01) :E26-E28

[25] Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F [J].

Shide, K. ;

Shimoda, H. K. ;

Kumano, T. ;

Karube, K. ;

Kameda, T. ;

Takenaka, K. ;

Oku, S. ;

Abe, H. ;

Katayose, K. S. ;

Kubuki, Y. ;

Kusumoto, K. ;

Hasuike, S. ;

Tahara, Y. ;

Nagata, K. ;

Matsuda, T. ;

Ohshima, K. ;

Harada, M. ;

Shimoda, K. .

LEUKEMIA, 2008, 22 (01) :87-95

[26] Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F [J].

K Shide ;

H K Shimoda ;

T Kumano ;

K Karube ;

T Kameda ;

K Takenaka ;

S Oku ;

H Abe ;

K S Katayose ;

Y Kubuki ;

K Kusumoto ;

S Hasuike ;

Y Tahara ;

K Nagata ;

T Matsuda ;

K Ohshima ;

M Harada ;

K Shimoda .

Leukemia, 2008, 22 :87-95

[27] JAK2 V617F Genotype Is a Strong Determinant of Blast Transformation in Primary Myelofibrosis [J].

Barosi, Giovanni ;

Poletto, Valentina ;

Massa, Margherita ;

Campanelli, Rita ;

Villani, Laura ;

Bonetti, Elisa ;

Viarengo, Gianluca ;

Catarsi, Paolo ;

Klersy, Catherine ;

Rosti, Vittorio .

PLOS ONE, 2013, 8 (03)

[28] STUDY OF MYELOFIBROSIS USING JAK2 V617F EXPRESSING MACROPHAGES [J].

Silyutina, Anna ;

Gin, Irina ;

Prikhodko, Stanislava ;

Butylin, Pavel ;

Zaritskey, Andrey .

EXPERIMENTAL HEMATOLOGY, 2017, 53 :S65-S65

[29] V617F mutations of the JAK2 gene in hematological neoplasms [J].

Mori, N. ;

Yoshinaga, K. ;

Tada, M. ;

Wang, Y-H. ;

Shiseki, M. ;

Motoji, T. .

EXPERIMENTAL HEMATOLOGY, 2006, 34 (09) :81-81

[30] 2 DIFFERENT PHENOTYPES IN ESSENTIAL THROMBOCYTHEMIA: MUTATION JAK2 V617F OR CALR [J].

Vilches Moreno, A. S. ;

Guerrero Fernandez, L. ;

Latorre Gonzalez, A. ;

Monteagudo Saiz, D. ;

Robles Marina, V ;

Andreu Costa, A. ;

Ayala Diaz, R. ;

Martinez Lopez, J. .

HAEMATOLOGICA, 2016, 101 :187-187

← 1 2 3 4 5 →